INTRODUCTION
============

Mitotic spindle orientation plays a critical role during tissue morphogenesis by regulating organ size and shape. It is also the foundation for asymmetric cell division, a key step for stem cells to function in generating cellular diversity ([@B23]; [@B39]; [@B63]; [@B22]; [@B49]).

During the asymmetric cell division of *Drosophila* neuroblasts and sensory organ precursor cells, the reorientation of mitotic spindle has been shown to require a protein called Partner of Inscuteable (Pins) and the Gα subunit of the heterotrimeric G proteins, which localize asymmetrically at the cell cortex during mitosis ([@B54]; [@B61], [@B60]; [@B20]; [@B78]; [@B8]). Gene products related to Pins (GPR1/2) and Gα are also essential for spindle positioning and displacement during asymmetric cell division of the *Caenorhabditis elegans* zygotes ([@B24]; [@B25]; [@B10]; [@B65]). Elegant laser cutting experiments and living-embryo time-lapse analysis suggest that GPR 1/2 and Gα subunits are required for generating unequal pulling forces on the mitotic apparatus ([@B26], [@B27]; [@B28]; [@B55]).

We showed previously that mammalian homologue of *Drosophila* Pins (LGN) functions as a conformational switch that links Gα~i~ and the nuclear mitotic apparatus (NuMA) protein and that LGN and Gα~i~ may exert forces on mitotic spindles in cultured mammalian cells ([@B14], [@B15]; [@B13]). Subsequent studies identified Mud from *Drosophila* and Lin5 in *C. elegans* as functional homologues of NuMA ([@B4]; [@B31]; [@B62]; [@B70]), suggesting the existence of an evolutionarily conserved protein complex in regulating spindle positioning. The in vivo function of mammalian Gα~i~/LGN/NuMA complex was not clear until recently. Accumulating evidence suggest that this ternary complex plays an important role in directing spindle orientation, not only in asymmetrically dividing stem/progenitor cells during development, but also in symmetrically dividing cells during epithelial morphogenesis ([@B50]; [@B40]; [@B29]; [@B57]; [@B79]; [@B3]; [@B17]; [@B16]; [@B56]; [@B75]; [@B80]; [@B45]; [@B77]).

Spindle positioning is believed to be regulated by the interaction between astral microtubules (MTs) and the cell cortex ([@B47]). How the cortical Gα/LGN/NuMA ternary complex is physically linked to astral MTs is not completely understood. Although NuMA can bind to MTs, it cannot do so when associated with LGN ([@B15]; [@B21]; [@B37]). Another plausible candidate is cytoplasmic dynein, the most abundant minus end--directed, microtubule-based motor protein complex ([@B33]). Studies from different systems suggest that cytoplasmic dynein and its functionally linked dynactin complex are involved in orienting mitotic spindles ([@B6]; [@B1]; [@B53]; [@B12]; [@B2]). The relationship between dynein and the Pins family of proteins is evident in asymmetrically dividing *C. elegans* zygotes, in which GPR-1/2 and Gα are linked to subunits of the dynein/dynactin complex in generating pulling forces on astral MTs ([@B26], [@B27]; [@B55]; [@B11]; [@B51]). More recently, the link between the ternary complex and cytoplasmic dynein was also established in mitotic HeLa cells ([@B68]; [@B76]; [@B38]). However, it is not clear which component of the ternary complex mediates the association with cytoplasmic dynein and how the association is regulated.

The current view of dynein-mediated force generation on astral MTs is that dynein is anchored at the cell cortex and interacts with astral MTs ([@B28]; [@B30]; [@B43]). How dynein is anchored and regulated at the cell cortex is not known. Furthermore, dynein was also observed to localize along astral MTs ([@B5]), and in principle, dynein movement along astral MTs can also produce pulling forces ([@B35]), although such evidence is missing in mitotic mammalian cells. Recent studies also suggest that cortical actin filaments are involved in spindle positioning, either intrinsically or in response to external cues ([@B66]; [@B69]; [@B42]; [@B19]). Whether and how actin filaments are linked to dynein-based force generator are not clear.

Here we show that LGN and cytoplasmic dynein heavy chain form a complex and regulate each other for their cortical localization and that actin filaments help to maintain LGN/dynein at the cell cortex and counteract astral microtubule--mediated cortical release and transport of LGN/dynein complex.

RESULTS
=======

Gα~i~-regulated association of LGN and dynein heavy chain, cytoplasmic 1 in mammalian cells
-------------------------------------------------------------------------------------------

To test whether LGN associates with the dynein/dynactin complex in mammalian cells, we performed immunoprecipitation analysis using Madin--Darby canine kidney (MDCK) cells that were partially synchronized in mitosis. As shown in [Figure 1A](#F1){ref-type="fig"}, anti-LGN antibodies, but not rabbit immunoglobulin G (IgG), could efficiently immunoprecipitate endogenous dynein heavy chain, cytoplasmic 1 (DYNC1H1). Small but specific amounts of dynein IC 1 (DYNC1I1) and dynactin subunit p150^Glued^ were also detected in the anti-LGN immunoprecipitates, indicating that endogenous LGN and cytoplasmic dynein form a complex. Our results are consistent with a recent study showing that ectopically expressed green fluorescent protein (GFP)--LGN forms a complex with cytoplasmic dynein in HeLa cells ([@B38]).

![Gα~i~-regulated interaction between LGN and DYNC1H1. (A) Endogenous LGN and cytoplasmic dynein form a complex. MDCK II cells were partially synchronized by treating with nocodazole (200 nM) for 12 h. After being released from the treatment for 40 min, cells were harvested and subjected to immunoprecipitation using anti-LGN antibodies or rabbit IgG. The immunoprecipitates were separated by SDS--PAGE and blotted using specific antibodies. (B) Gα~i~ enhances the association between LGN and DYNC1H1. Cos 7 cells were transfected as indicated. Cell lysates (1/30 of total) and immunoprecipitates were separated in a 6% SDS--PAGE gel and blotted using specific antibodies. Note that in 6% gel, myc-Gα~i~1 comigrated with and was masked by the light chain of anti-HA antibody in the HA-LGN immunoprecipitates. (C) Gα~i~, LGN, and DYNC1H1 form a complex in vivo, independent of NuMA. Cos 7 cells were transfected as indicated. Cell lysates (1/30 of total) and immunoprecipitates were separated in a 7% SDS--PAGE gel and blotted. (D) The GoLoco-insensitive Gα~i~1 cannot associate with LGN and DYNC1H1. Cos 7 cells were transfected as indicated. Cell lysates were subjected to analysis as in C.](901fig1){#F1}

Because DYNC1H1 turned out to be the major coimmunoprecipitate of LGN, we further studied the interaction between LGN and DYNC1H1 by coexpressing full-length DYNC1H1 and LGN in Cos 7 cells. Immunoprecipitation of HA-LGN resulted in the coprecipitation of Venus-DYNC1H1 ([Figure 1B](#F1){ref-type="fig"}), further suggesting that they can form a complex in vivo. The C-terminus of LGN contains four GoLoco motifs that bind to GDP-bound Gα~i/o~ ([@B44]; [@B74]). LGN is normally in its closed conformation due to intramolecular interactions, and Gα~i~ binding could switch LGN to an open state ([@B13]). To test the effect of Gα~i~ on the association between LGN and DYNC1H1, we included Gα~i~1 in the cotransfection and immunoprecipitation experiments. Of interest, coexpression of myc-Gα~i~1 led to obviously enhanced coimmunoprecipitation of Venus-DYNC1H1 with HA-LGN ([Figure 1B](#F1){ref-type="fig"}), suggesting that the association between LGN and DYNC1H1 might rely on the conformation of LGN and could be regulated by Gα~i~1 binding.

Next we tested whether DYNC1H1, LGN, and Gα~i~ can form a complex in vivo by transfecting cells with different combinations of Gα~i~1, LGN, and DYNC1H1. As shown in [Figure 1C](#F1){ref-type="fig"}, myc-Gα~i~1 could efficiently immunoprecipitate HA-LGN (lanes 3 and 10). In the absence of HA-LGN, myc-Gα~i~1 could immunoprecipitate little, if any, Venus-DYNC1H1 (lanes 1 and 8). However, when HA-LGN was coexpressed, myc-Gα~i~1 could efficiently immunoprecipitate Venus-DYNC1H1 (lanes 5 and 12), suggesting that Gα~i~1, LGN, and DYNC1H1 can form a ternary complex in vivo.

We showed previously that NuMA can also bind to LGN and form a complex with LGN and Gα~i~ ([@B13]). NuMA was also shown to associate with dynein/dynactin complex in *Xenopus* egg extracts ([@B48]). It is possible that endogenous NuMA is mediating the association between Gα~i~/LGN and DYNC1H1. To test the effect of NuMA on the DYNC1H1/LGN/Gα~i~ complex formation, we included NuMA in the cotransfection experiments. Whereas myc-Gα~i~1 can immunoprecipitate HA-NuMA in the presence of HA-LGN ([Figure 1C](#F1){ref-type="fig"}, lanes 6 and 13), coexpression of HA-NuMA resulted in reduced Venus-DYNC1H1 in the myc-Gα~i~1/HA-LGN complex (lanes 7 and 14), suggesting that Gα~i~1/LGN/DYNC1H1 complex formation is unlikely to be mediated through NuMA.

To exclude the possibility that the association between DYNC1H1 and Gα~i~1 is mediated through other Gα~i~1-binding proteins such as G~β/γ~ ([@B58]), we used a GoLoco-insensitive Gα~i~ mutant (Gα~i~1-N149I) as a control. This mutant Gα~i~1 specifically lacks the ability to bind to the GoLoco motif but is otherwise equivalent to wild-type Gα~i~1 in terms of other functional aspects, including binding to G β/γ subunits ([@B73]). As shown in [Figure 1D](#F1){ref-type="fig"}, whereas wild-type Gα~i~1 could efficiently immunoprecipitate LGN and DYNC1H1, the GoLoco-insensitive Gα~i~1 mutant failed to do so, suggesting that the Gα~i~1/DYNC1H1 complex formation is mediated through LGN.

LGN is necessary and sufficient for the cortical localization of DYNC1H1 during mitosis
---------------------------------------------------------------------------------------

The interaction between LGN and DYNC1H1 prompted us to test whether LGN is required for the cortical localization of DYNC1H1. Cortical localization of dynactin subunits in MDCK cells had been described ([@B5]; [@B18]). Using an antibody against DYNC1H1, we could detect both spindle and cortical localization of DYNC1H1 ([Figure 2A](#F2){ref-type="fig"}). The authenticity of the antibody staining was verified by using two different short hairpin RNAs (shRNAs) against canine DYNC1H1, which, upon expression, significantly eliminated the cortical and spindle staining of DYNC1H1 (Supplemental Figure S1). We then compared DYNC1H1 staining between control and stable LGN knockdown cells that we established previously ([@B79]). Remarkably, depletion of LGN led to significantly reduced cortical localization of DYNC1H1, whereas the spindle localization of DYNC1H1 appeared normal ([Figure 2, A and B](#F2){ref-type="fig"}). These results are consistent with recent studies in HeLa cells showing that LGN is required for mitotic cortical localization of dynein/dynactin subunits ([@B76]; [@B38]).

![LGN is required for the cortical localization of DYNC1H1 during mitosis. (A) LGN depletion results in reduced cortical localization of DYNC1H1. MDCK cells transduced by control lentivirus (control) or lentivirus expressing shRNAs targeting different regions of LGN (LGN-KD1-7 and LGN-KD2-6) were stained with anti-DYNC1H1 antibody and DNA dye. Bar, 10 μm. (B) Quantitation of the fluorescence intensity of cortical DYNC1H1 from images acquired in A. *n* = 50 for each set; \**p* \< 0.01. (C) Slight overexpression of LGN leads to enhanced cortical localization of DYNC1H1. Stable Tet-Off MDCK cells expressing Venus-LGN were cultured in the presence (+Dox) or absence (--Dox) of doxycycline. At 24 h later, cells were stained as in A. Bar, 10 μm. (D) Quantitation of the fluorescence intensity of cortical DYNC1H1 from images acquired in C. *n* = 50 for each set; \**p* \< 0.01.](901fig2){#F2}

We had established inducible MDCK cell lines that slightly overexpress Venus-tagged LGN ([@B13]). Slight overexpression of LGN led to enhanced cortical localization of LGN and profound spindle oscillation, suggesting unbalanced forces on astral MTs ([@B13]). We used these cell lines to test the effect of LGN overexpression on DYNC1H1 localization during mitosis. Of interest, slight overexpression of Venus-LGN resulted in significantly enhanced cortical localization of DYNC1H1 ([Figure 2, C and D](#F2){ref-type="fig"}). These data suggest that LGN is capable of recruiting DYNC1H1 to the cell cortex during mitosis, and, most important, endogenous LGN is required for the cortical localization of DYNC1H1 during mitosis.

Dynein and astral MTs regulate the cortical localization of LGN
---------------------------------------------------------------

Surprisingly, when we compared the localization of endogenous LGN in control and DYNC1H1-knockdown cells, we found that the cortical localization of LGN was obviously enhanced in DYNC1H1-knockdown cells ([Figure 3, A and C](#F3){ref-type="fig"}), suggesting that DYNC1H1 also regulates LGN localization. As the minus end--directed motor protein, cortical dynein is believed to exert its function through astral MTs. We wondered whether disrupting astral MTs would also affect LGN distribution. We treated cells with low doses of nocodazole, which is generally used to disrupt astral MTs ([@B32]). Indeed, treating MDCK cells with 50 nM nocodazole led to significant loss of astral MTs, whereas the spindle MTs were not affected (Supplemental Figure S2). Of interest, disruption of astral MTs also led to enhanced cortical localization of LGN ([Figure 3, B and C](#F3){ref-type="fig"}). Thus, whereas LGN is required for the cortical recruitment of dynein, dynein also regulates cortical LGN through astral MTs.

![Knocking down DYNC1H1 or disrupting astral MTs leads to enhanced cortical localization of LGN. (A) MDCK cells were transfected with plasmids expressing control shRNA (control) or shRNAs targeting DYNC1H1 (shRNA1 and shRNA2). At 48 h later, cells were fixed and stained with anti-LGN, anti--α-tubulin antibodies, and DNA dye. Bar, 10 μm. (B) MDCK cells were cultured in media containing 50 nM nocodazole for 40 min. Cells were then fixed and stained as in A. Bar, 10 μm. (C) Quantitation of the fluorescence intensity of cortical LGN from images acquired in A and B. *n* = 50 for each set; \**p* \< 0.01.](901fig3){#F3}

Dynein- and astral MT--dependent turnover of cortical LGN
---------------------------------------------------------

The fact that cortical LGN is modulated by dynein and astral MTs led us to speculate that it might be dynamic. We performed fluorescence recovery after photobleaching (FRAP) experiments to study the kinetics of cortical LGN using our Venus-LGN cell line. As we showed previously ([@B13]), in live MDCK cells, cortical Venus-LGN usually exhibits a patchy distribution ([Figure 4A](#F4){ref-type="fig"}), which is consistent with a recent report showing that GFP-DYNC1H1 also shows patchy localization at the cell cortex ([@B9]). Our FRAP analysis indicated that; indeed the fluorescence of cortical Venus-LGN recovered gradually after photobleaching, suggesting dynamic turnover ([Figure 4](#F4){ref-type="fig"} and Supplemental Movie S1). Next we set out to test whether astral MTs and DYNC1H1 are involved in the dynamic turnover of cortical LGN. We carried out similar FRAP experiments under conditions when astral MTs were disrupted using low doses of nocodazole or DYNC1H1 was knocked down by specific shRNA. Of interest, the fluorescence recovery of cortical Venus-LGN was significantly inhibited under both conditions ([Figure 4, A--E](#F4){ref-type="fig"}, and Supplemental Movies S2 and S3), suggesting that astral MTs and DYNC1H1 contribute to the dynamic turnover of cortical LGN.

![Dynamic turnover of cortical LGN relies on astral MTs and DYNC1H1. (A) FRAP analysis of cortical LGN. Representative images from live-cell time-lapse series were shown. The photobleaching areas were marked by squares. Stable MDCK cells expressing Venus-LGN were either untreated (top), treated with 50 nM nocodazole for 1 h (middle), or transfected with DYNC1H1 shRNA for 48 h (bottom) before being subjected to FRAP analysis. (B--E) Quantitative analysis of FRAP experiments. (B, D) Plots of normalized fluorescence intensity of cortical Venus-LGN in cells treated with DMSO (B, blue diamonds), 50 nM nocodazole (B, pink squares), or transfected with control shRNA (D, blue diamonds) or DYNC1H1 shRNA (D, pink squares) vs. time (in seconds) after photobleaching. Data are expressed as mean ±SEM (*n* = 8 for each set). (C, E) The mobile fractions of cortical Venus-LGN in control, nocodazole-treated, or DYNC1H1-knockdown cells were calculated from the fluorescence recovery curves shown in B and D. Data are expressed as mean ±SEM. \**p* \< 0.01. (F) Association of Venus-LGN with astral MTs. MDCK cells expressing Venus-LGN were preextracted with microtubule stabilization buffer containing 0.2% Triton X-100 and then fixed with 4% PFA. Fixed cells were stained with anti-LGN (green), anti--α-tubulin (red) antibodies, and DNA dye (blue). Bar, 10 μm.](901fig4){#F4}

It is possible that astral MTs and dynein-dependent turnover of cortical LGN are mediated through the dissociation of LGN from the dynein complex into cytosol when astral MTs reach the cell cortex. Alternatively, LGN might be transported by dynein along astral MTs. To distinguish these possibilities, we asked whether we could detect LGN on astral MTs. Indeed, in Venus-LGN cells, we observed LGN localization along astral MTs by using either the anti-LGN antibody ([Figure 4F](#F4){ref-type="fig"}) or the anti-GFP antibody (unpublished data). Of note, Venus-LGN was not observed to localize on spindle MTs.

Dynein and astral MTs mediate transport of LGN from cell cortex to spindle poles
--------------------------------------------------------------------------------

The cortical localization of LGN and dynein appears to rely on actin filaments ([@B5]; [@B34]; [@B68]), although the underlying mechanism is not known. Indeed, LGN dissociated from the cell cortex during mitosis when MDCK cells were treated with latrunculin A (LatA; [Figure 5A](#F5){ref-type="fig"}), a drug that depolymerizes actin filaments ([@B64]; Supplemental Figure S3). Consistent with previous studies in HeLa cells ([@B69]), disruption of actin filaments led to spindle misorientation in MDCK cells, although the overall spindle organization appeared normal (unpublished data). Of interest, although we could hardly detect spindle pole localization of endogenous LGN in untreated MDCK cells, we observed an obvious accumulation of LGN at the spindle poles in cells treated with LatA ([Figure 5, A and B](#F5){ref-type="fig"}, and Supplemental Figure S3A). Of importance, the spindle pole accumulation of the anti-LGN staining was not observed in LGN-stable knockdown cells treated with LatA (Supplemental Figure S3B), indicating that it was endogenous LGN that translocated to the spindle poles when actin filaments were disrupted. Furthermore, after we washed out LatA from the cells, LGN regained cortical localization and disappeared from the spindle poles ([Figure 5A](#F5){ref-type="fig"}). Similar results were observed when cells were treated with cytochalasin D, another inhibitor of actin filaments (unpublished data).

![Disruption of actin filaments leads to astral microtubule-- and dynein-dependent cortical dissociation and spindle pole accumulation of LGN. (A) MDCK II cells were either untreated (Control) or treated as labeled. LatA: 1 μM of LatA for 45 min; Nocodazole + LatA: 50 nM of nocodazole plus 1 μM of LatA for 45 min; DYNC1H1 shRNA-1, -2 + LatA: transfected with DYNC1H1 shRNA-1 or -2 for 48 h and then treated with 1 μM LatA for 45 min. MG132, 5 μM, was added 1 h before treatments and maintained during treatments. Cells were fixed after treatments and stained with anti-LGN (green), anti--α-tubulin (red) antibodies, and DNA dye (blue). (B) Quantitation of LGN signals at spindle poles as described in *Materials and Methods*. *n* = 50 for each set; \**p* \< 0.01.](901fig5){#F5}

The aforementioned observations---cortical LGN underwent astral MTs and dynein-dependent turnover, and LGN was detected along astral MTs ([Figure 4](#F4){ref-type="fig"})---led us to wonder whether LatA-induced cortical dissociation and spindle pole accumulation of LGN are mediated through an active transport process that involved astral MTs and dynein. If so, we would expect that blocking such transport might attenuate the effect of LatA on LGN. To test this hypothesis, we included low doses of nocodazole in the LatA treatment. Strikingly, the presence of nocodazole significantly preserved the cortical localization of LGN and inhibited the spindle pole accumulation of LGN ([Figure 5, A and B](#F5){ref-type="fig"}). It is noteworthy that nocodazole-mediated preservation of cortical LGN was not due to incomplete disruption of actin filaments (Supplemental Figure S3A). Similar results were obtained when DYNC1H1-knockdown cells were treated with LatA ([Figure 5, A and B](#F5){ref-type="fig"}), suggesting that the translocation of LGN after LatA treatment requires astral MTs and cytoplasmic dynein. To explore whether such phenomena are specific to adherent, polarized epithelial cells, we performed identical experiments in MDA-231 and HeLa cells and observed similar results (Supplemental Figure S4 and unpublished data).

Astral MTs mediate release and transport of cortical dynein and NuMA when actin filaments are disrupted
-------------------------------------------------------------------------------------------------------

We showed that LGN forms a complex with DYNC1H1 and is required for the cortical localization of DYNC1H1 ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). If LGN is transported by cortical dynein, we would expect dissociation of DYNC1H1 from the cortex when cells were treated with LatA. We used our Venus-LGN cell line to investigate the distribution of DYNC1H1, as more robust cortical staining of DYNC1H1 was observed in these cells ([Figure 2C](#F2){ref-type="fig"}). As shown in [Figure 6A](#F6){ref-type="fig"} (second from top), LatA treatment led to diminished cortical localization of Venus-LGN and endogenous DYNC1H1. We also observed more Venus-LGN and DYNC1H1 accumulating at the spindle poles ([Figure 6A](#F6){ref-type="fig"}, second from top). Intriguingly, including low doses of nocodazole prevented LatA-induced cortical dissociation and spindle pole accumulation of Venus-LGN and DYNC1H1 ([Figure 6, A](#F6){ref-type="fig"}, second from bottom, and [B](#F6){ref-type="fig"}), further suggesting that dynein-mediated transport of LGN underlies the observed translocation of LGN upon disruption of actin filaments. These results also suggest that the cortical targeting of LGN/DYNC1H1 complex may not require actin filaments. It is still possible, however, that actin filaments are required for the initial cortical targeting of LGN/DYNC1H1 complex before the LatA plus nocodazole treatment. To clarify this issue, we pretreated cells with LatA to dissociate LGN/DYNC1H1 complex from the cell cortex and then added low doses of nocodazole while maintaining same amount of LatA in the medium. Such treatments resulted in significant relocalization of Venus-LGN and DYNC1H1 to the cell cortex ([Figure 6, A](#F6){ref-type="fig"}, bottom, and [B](#F6){ref-type="fig"}). Live-cell analysis also revealed LatA-induced cortical dissociation and spindle pole accumulation of Venus-LGN and the rescue effect of nocodazole in the presence of LatA (Supplemental Figure S5). These results indicate that LGN-mediated cortical targeting of dynein does not require actin filaments, and actin filaments may serve to maintain LGN/dynein at the cell cortex during mitosis.

![Disruption of actin filaments leads to astral microtubule--dependent cortical dissociation and spindle pole accumulation of DYNC1H1 and NuMA. (A) Venus-LGN--expressing cells were treated as in [Figure 5A](#F5){ref-type="fig"} except for the results at the bottom, for which cells were first treated with 1 μM LatA for 45 min and then treated with 1 μM LatA plus 50 nM nocodazole for another 45 min. Cells were stained with anti-DYNC1H1 antibody (red) and DNA dye (blue). (B) Quantitation of cortical DYNC1H1 fluorescence intensity as described in *Materials and Methods*. *n* = 50 for each set; \**p* \< 0.01. (C) Venus-LGN--expressing cells were treated as in A. Cells were stained with anti-NuMA antibody (red) and DNA dye (blue). Second from top, arrow points to the original crescent-shaped NuMA, and arrowhead points to NuMA accumulated at the spindle pole. (D) Quantitation of cortical NuMA fluorescence intensity. *n* = 50 for each set; \**p* \< 0.01. Bars, 10 μm.](901fig6){#F6}

Next we tested whether NuMA also follows a similar pattern as LGN and dynein. In untreated Venus-LGN cells, in addition to the well-known crescent-shaped structure near the spindle poles, endogenous NuMA was also observed at the cell cortex and along astral MTs ([Figure 6C](#F6){ref-type="fig"}, top). After LatA treatment, NuMA dissociated from the cell cortex and was often seen to accumulate and colocalize with Venus-LGN at the spindle poles ([Figure 6, C](#F6){ref-type="fig"}, middle, arrowhead, and [D](#F6){ref-type="fig"}) adjacent to the original crescent ([Figure 6C](#F6){ref-type="fig"}, middle, arrow). Disrupting astral MTs blocked LatA-induced dissociation of NuMA from the cell cortex ([Figure 6, C](#F6){ref-type="fig"}, bottom, and [D](#F6){ref-type="fig"}). Similar results were observed in MDA-231 cells (Supplemental Figure S4).

Astral microtubule-- and LGN-mediated transport of Gα~i~
--------------------------------------------------------

Because Gα~i~ binds to LGN and regulates the association between LGN and DYNC1H1, we studied the effect of LatA treatment on the distribution of endogenous Gα~i~. In untreated MDCK cells, Gα~i~3 localized at the cell cortex in a similar pattern as LGN ([Figure 7A](#F7){ref-type="fig"}). Of interest, LatA treatment resulted in significant cortical reduction and spindle pole accumulation of Gα~i~3 ([Figure 7, A and B](#F7){ref-type="fig"}), which is reminiscent of the effects of LatA on the distribution of LGN, DYNC1H1, and NuMA. Furthermore, the effect of LatA on the localization of Gα~i~3 could be inhibited by low concentrations of nocodazole ([Figure 7, A and B](#F7){ref-type="fig"}), suggesting that it was mediated by astral MTs. To test whether LatA-induced translocation of Gα~i~3 was mediated through LGN, we compared control and LGN-knockdown cells. Consistent with previous work ([@B76]; [@B38]), knockdown of LGN did not obviously affect the membrane association of Gα~i~3 in untreated cells ([Figure 7, C and D](#F7){ref-type="fig"}). However, in the absence of LGN, LatA treatment did not lead to spindle pole accumulation of Gα~i~3 ([Figure 7, C and D](#F7){ref-type="fig"}). These results suggest that when actin filaments were disrupted, cortical Gα~i~3 was also transported to the spindle poles along astral MTs through the LGN/dynein complex.

![Disruption of actin filaments leads to astral microtubule-- and LGN-dependent cortical release and spindle pole accumulation of Gα~i~3. (A) MDCK II cells were treated as in [Figure 5A](#F5){ref-type="fig"}. Cells were fixed after treatments and stained with anti-Gα~i~3 (green), anti--α-tubulin (red) antibodies, and DNA dye (blue). (B) Quantitation of cortical Gα~i~3 fluorescence intensity. *n* = 50 for each set; \**p* \< 0.01. (C) Stable MDCK cells expressing control shRNA (top two) or shRNA against LGN (bottom two) were either untreated (control) or treated with 1 μM of LatA for 45 min (LatA). Cells were fixed and stained with anti-Gα~i~3 (red) and DNA dye (blue). (D) Quantitation of Gα~i~3 signals at spindle poles as described in *Materials and Methods*. *n* = 50 for each set; \**p* \< 0.01.](901fig7){#F7}

Astral microtubule--mediated transport is important for the establishment of bipolar, symmetrical cortical LGN distribution during metaphase
--------------------------------------------------------------------------------------------------------------------------------------------

To maintain spindle positioning within a cell, cortical cues that exert forces on astral MTs need to be placed at confined regions of the cell cortex. Indeed, in metaphase HeLa cells, LGN is enriched at regions of the cell cortex that are close to the spindle poles, correlating perfectly with the spindle axis ([@B38]; [@B45]). Recently a chromosome-associated Ran-GTP mechanism was proposed for excluding LGN from cortical regions near the spindle midzone ([@B38]). However, whether this mechanism can wholly account for the establishment of LGN distribution during metaphase is not clear. Our finding of dynein- and astral microtubule--mediated dynamic turnover of cortical LGN led us to test whether it is also involved in installing LGN at the cell cortex. We synchronized HeLa cells using thymidine block and arrested cells in mitosis with monastrol, an Eg5 kinesin inhibitor that prevents centrosome separation ([@B46]). In monastrol-arrested cells, LGN exhibited either diffused cortical localization or slight enrichment at one side of the cell cortex ([Figure 8A](#F8){ref-type="fig"}, left). We then washed out monastrol and incubated cells in medium containing MG132, a proteasome inhibitor that prevents anaphase onset ([@B36]). One hour after monastrol washout, most of the mitotic cells had established bipolar spindles attached to properly aligned chromosomes ([Figure 8A](#F8){ref-type="fig"}, middle). In these cells, LGN showed confined, bipolar and symmetrical distribution at cortical regions facing the spindle poles and was excluded from the central cell cortex ([Figure 8A](#F8){ref-type="fig"}, middle), identical to its localization in untreated metaphase cells. Thus the monastrol washout experiments allowed us to study how the spatial arrangement of cortical LGN was achieved. To test whether astral MTs were involved, we included 20 nM nocodazole in the medium after monastrol washout. Of interest, such low concentration of nocodazole treatment led to LGN mislocalization in a large portion of cells with apparently normal chromosome alignment and bipolar spindle formation ([Figure 8, A](#F8){ref-type="fig"}, right, and [B](#F8){ref-type="fig"}), although the chromosome-mediated exclusion mechanism appeared to be working in most of the cases. These results suggest that astral MTs, and probably astral microtubule-mediated shuttling and subsequent recycling of cortical LGN, are required for establishing proper LGN distribution at the cell cortex.

![Astral MTs are required for establishing bipolar, symmetrical cortical LGN distribution during metaphase. (A) HeLa cells were partially synchronized by treating with 2 mM thymidine for 16 h. After release in normal medium for 8 h, cells were treated with 50 mM monastrol for 3 h. Monastrol-arrested cells were either directly fixed (left) or washed and released in normal medium containing 5 μM MG132 (middle) or 5 μM MG132 plus 20 nM nocodazole (right) for 1 h and fixed. Fixed cells were stained with anti-LGN (green), anti--α-tubulin (red) antibodies, and DNA dye (blue). Bar, 10 μm. (B) Quantitation of bipolar, symmetrical cortical LGN localization. Only cells with normal chromosome condensation and alignment were included in the quantification. *n* = 100 from three independent experiments; \**p* \< 0.001. (C) Schematic working model illustrating astral microtubule--mediated transport and recycling of the Gα/LGN/dynein/NuMA complex during mitosis.](901fig8){#F8}

DISCUSSION
==========

Proper spindle positioning is believed to be achieved when astral MTs receive confined cortical forces ([@B28]). The evolutionarily conserved Gα/LGN/NuMA ternary complex has emerged as an important cortical force generator ([@B23]; [@B39]; [@B63]), but how this complex exerts forces on astral MTs is not clear.

Here we show that Gα~i~, LGN, and DYNC1H1 form a complex in mammalian cells. Of interest, Gα~i~ binding enhances the association between LGN and DYNC1H1, further supporting the conformation switch hypothesis for the Pins family of proteins ([@B13]; [@B52]). It also suggests that regulators of Gα~i~ may affect the interaction between LGN and DYNC1H1. Our results, together with recent studies in HeLa cells ([@B76]; [@B38]), indicate that LGN serves as a major cortical factor that recruits cytoplasmic dynein to the cell cortex during mitosis, probably through membrane-bound Gα. It is surprising that NuMA, the other LGN-binding partner, has an inhibitory effect on the association between Gα~i~/LGN and DYNC1H1. NuMA was shown to associate with cytoplasmic dynein in *Xenopus* egg extracts ([@B48]). While the manuscript was under revision, [@B41]) reported that the N-terminal of NuMA associates with cytoplasmic dynein, although a direct physical link with a specific dynein subunit is still missing. Our results suggest that Gα~i~/LGN and DYNC1H1 might form a complex in a NuMA-independent manner. It is possible, however, that in our immunoprecipitation analysis, the overexpressed NuMA might sequester DYNC1H1 to a cellular compartment that is not accessible for the Gα~i~/LGN complex. Nevertheless, we showed that NuMA also localizes to astral MTs and is transported to the spindle poles when actin filaments are disrupted, suggesting that it is in a complex with LGN and dynein. We propose that NuMA may associate with other component of the dynein/dynactin complex and function with LGN in recruiting or modulating dynein at the cell cortex during mitosis. Further studies are needed to determine whether the association between LGN and DYNC1H1 is direct or indirect and how the interaction is regulated by related proteins.

A prevalent view of dynein function in spindle positioning is that dynein is anchored at the cell cortex and exerts forces on astral MTs either by controlling microtubule dynamics or by driving microtubule sliding along the cell cortex ([@B28]; [@B30]; [@B43]). We now provide evidence that cortical dynein may not be static; instead, it can be released and move, in complex with LGN and NuMA, along astral MTs. The movement of the dynein complex along astral MTs may generate pulling forces, as astral MTs could also be captured by other cortical microtubule-binding proteins rather than dynein ([@B59]). Alternatively, the release and transport of dynein complex may provide a novel mechanism for mammalian cells to limit, balance, or terminate cortical dynein-generated pulling forces. Our results are consistent with a recent study in *C. elegans* suggesting that MTs regulate cortical localization of GPR-1/2 ([@B72]). It would be interesting to test whether dynein-mediated transport of LGN could be applied to other systems.

An interesting phenomenon that has been observed in multiple mammalian cell lines is that, during metaphase, LGN exhibits bipolar, symmetrical cortical localization, which correlates nicely with spindle orientation, suggesting an intrinsic mechanism for spindle positioning. How is the confined LGN distribution established? Recently an elegant chromosome-mediated, cortical exclusion model was proposed ([@B38]), although the underlying mechanism is not clear. Here we show that astral MTs are also required for proper cortical LGN distribution, suggesting the involvement of multiple mechanisms. We propose that astral MT--mediated transport and recycling may help to sort and enrich LGN at cortical regions facing the spindle poles, where the interaction between astral MTs and the cell cortex should be more intensive.

It is intriguing to observe that when actin filaments were disrupted, endogenous Gα~i~ also dissociated from the cell cortex and accumulate at the spindle poles in an astral microtubule-- and LGN-dependent manner. The membrane localization of Gα~i~ is mediated through cotranslational or posttranslational lipid modification ([@B7]) and, in principle, should not be affected by cortical actin filaments. We propose that during mitosis, a large portion of Gα~i~ is associated with LGN at the cell cortex in MDCK cells. Dynein-generated force could overcome the membrane attachment of Gα~i~. Alternatively, other mitotic-specific mechanisms, such as depalmitoylation, may exist. In line with our hypothesis, a recent study in *C. elegans* revealed that the Gβ subunit GBP-1, a negative regulator of Gα/GPR1,2 complex, has the lowest membrane level during mitosis ([@B67]). We are in the process of testing whether Gβ/γ and other Gα~i~ regulators are involved in the transport of LGN/Gα~i~.

The relationship between cortical actin filaments and dynein has long been an enigma. Previous studies suggest that actin filaments are required for the cortical localization of LGN and dynein subunits ([@B5]; [@B34]; [@B68]). Through careful analysis, we found that cortical dissociation of LGN and dynein upon disruption of actin filaments is not a simple event of anchorage detachment but involves astral MT--mediated transportation. We now provide a more definitive link between cortical actin filaments and the LGN/dynein complex. Our results suggest that actin filaments are not required for the cortical targeting of LGN/dynein; instead, they serve as a stabilizing structure to maintain the LGN/dynein complex at the cell cortex. We propose the existence of actin filament--associated or regulated protein(s) that links the LGN complex to cortical actin filaments and counteracts astral MT--mediated release of LGN/dynein complex. Such actin filament--mediated maintenance of cortical LGN/dynein may sustain dynein-generated forces or serve as a rate-limiting factor---by regulating the release and transport of the LGN/dynein complex---in modulating pulling forces on astral MTs under different physiological conditions.

Taking our results together, we propose the following working hypothesis ([Figure 8C](#F8){ref-type="fig"}): membrane-associated Gα recruits LGN to the cell cortex, which in turn recruits NuMA and dynein. Cortical Gα/LGN/dynein/NuMA complex is stabilized and maintained by actin filaments through unknown factor(s). The interaction between astral MTs and the cell cortex is accompanied by constant release and transport of a portion of the Gα/LGN/dynein/NuMA complex from the cell cortex to spindle poles. Once reaching the spindle poles, the Gα/LGN/dynein/NuMA complex leaves the spindle poles and recycles back to the cell cortex. When dynein is knocked down or in the absence of astral MTs, the cortical release and transport of LGN will be compromised, and more LGN will be trapped at the cell cortex. On the other hand, when cortical actin filaments are disrupted, astral MTs mediate rapid release and transport of the Gα/LGN/dynein/NuMA complex, leading to its spindle pole accumulation. The cortical release, transport, and recycling of LGN is important for establishing the bipolar, symmetric cortical distribution of LGN during metaphase. The transport of LGN/dynein complex may also generate pulling forces on astral MTs or serve as a regulatory mechanism in balancing the pulling forces on astral MTs. Further studies are needed to elucidate how the dynamic behavior of cortical LGN complex is regulated at the molecular level and, of importance, to what extent the regulated transport of LGN/dynein complex contributes to spindle positioning.

MATERIALS AND METHODS
=====================

Cell lines and reagents
-----------------------

Cos 7 and MDCK cells were maintained in DMEM (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum and antibiotics at 37°C in a humidified 5% CO~2~ atmosphere. Control, LGN-stable knockdown MDCK cell lines and Tet-Off MDCK cell line expressing Venus-LGN were described previously ([@B13]; [@B79]).

Rabbit anti-LGN antibodies were described previously ([@B13]). Rabbit anti-NuMA antibody was a kind gift from Duane Compton (Dartmouth Medical School, Hanover, NH). The following antibodies were also used: primary monoclonal 9E10 anti-myc, 12CA5 anti-hemagglutinin (HA; Santa Cruz Biotechnology, Santa Cruz, CA), anti-dynein (IC, DYNC1I1; clone 70.1; Sigma-Aldrich, St. Louis, MO), anti-p150^Glued^ (Cell Signaling Technology, Danvers, MA), polyclonal rabbit anti-DYNC1H1, anti-Gα~i~3 (Santa Cruz Biotechnology), and anti-GFP (Torry Pines Biolabs, Secaucus, NJ); secondary Alexa 488, Alexa 594, Alexa 660, and Alexa 680 (Invitrogen, Carlsbad, CA) and IRDye800-conjugated (Rockland ImmunoChemicals, Gilbertsville, PA) goat anti-mouse or rabbit antibodies. Rhodamine--phalloidin was from Invitrogen; nocodazole, latrunculin A, monastrol, and MG132 were from Sigma-Aldrich.

Plasmids
--------

Full-length human DYNC1H1 cDNA was transferred from KIAA cDNA clone (0325; Kazusa DNA Research Institute, Kisarazu, Japan) by PCR and restriction enzyme digestion and cloned in pK-VENUS ([@B14]). Human NuMAcDNA was PCR amplified and cloned into pKHA3 to generate pKHA3-NuMA. Wild-type Gα~i~1 constructs were described previously ([@B13]). Mutant Gα~i~1 (N149I) was PCR amplified and cloned into pKmyc. For knocking down DYNC1H1 in MDCK cells, we used the pRNAi-neo plasmid (Biosettia, San Diego, CA) and the following target sequences: 5′-GCTGAAATCTGAAGCACTTAA-3′ (DYNC1H1 shRNA-1) and 5′-GCACTTAAAGATCGCCATTGG-3′ (DYNC1H1 shRNA-2).

Immunoprecipitation and Western blotting
----------------------------------------

Cos 7 cells were electroporated with mammalian expression vectors using an Amaxa Nucleofection device (Lonza, Basel, Switzerland) following the manufacturer\'s instructions. Cells were collected in lysis buffer (25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\], pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 0.5 mM EDTA, 5 mM MgCl~2~, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride \[PMSF\], 10 μg/ml leupeptin, 20 μg/ml aprotinin, and 20 μg/ml pepstatin). Equal amounts of cell lysate were incubated with 2 μg of anti-myc, anti-HA, anti-LGN antibodies or rabbit IgG at 4°C for 2 h or overnight. GammaBind-Plus Sepharose beads (GE Healthcare, Pittsburgh, PA) were added, and the mixture was incubated for 1 h at 4°C. Beads were washed four times with cell lysis buffer, and bound proteins were separated by SDS--PAGE. Proteins were transferred to nitrocellulose membrane and detected using anti-myc (1:1000), anti-HA (1:2000), anti-LGN (1:500), anti-GFP (1:2000), anti-DYNC1H1 (1:200), anti-DYNC1I1 (1:1000), or anti-p150^Glued^ (1:1000) antibodies.

Immunofluorescence microscopy
-----------------------------

Cells were grown on poly-lysine--coated coverglass and fixed using either 4% paraformaldehyde (PFA) or 4% PFA/0.25% Triton X-100 in phosphate-buffered saline (PBS) as indicated. For detecting astral MT localization of LGN or cortical localization of DYNC1H1 and NuMA, cells were preextracted using PHEM buffer (25 mM HEPES, 60 mM 1,4-piperazinediethanesulfonic acid, 10 mM ethylene glycol tetraacetic acid, 2 mM MgCl~2~, pH 6.9) containing 0.2% Triton X-100 and fixed in 4% PFA. Fixed cells were blocked with 1% bovine serum albumin/10% normal goat serum in PBS for 1 h and incubated in primary antibodies for 1 h at room temperature or overnight at 4°C. Cells were then washed and incubated for 1 h with the DNA dye Hoechst 33342 and secondary antibodies coupled with Alexa 488 or Alexa 594 (Invitrogen). A SlowFade Gold AntiFade kit (Invitrogen) was used to reduce photobleaching. Cells were imaged using either a 60×/numerical aperture (NA) 1.2 oil-immersion objective on a Nikon TE2000 inverted microscope (Nikon Instruments, Melville, NY) or a 63×/NA 1.4 objective on a Zeiss 510 LSM confocal microscope (Carl Zeiss, Oberkochen, Germany).

Measurement of the relative fluorescence intensity of cortical and spindle pole LGN and Gα~i~3 and of cortical NuMA and DYNC1H1
-------------------------------------------------------------------------------------------------------------------------------

Measurements of the relative fluorescence intensity of cortical LGN or DYNC1H1 were performed as described ([@B71]). Briefly, cells were stained with identical procedure, and images were taken with identical microscopic settings. Fifty metaphase cells in each group were randomly selected, and the mean fluorescence intensity of cortical LGN or DYNC1H1 was measured using ImageJ software (National Institutes of Health, Bethesda, MD). The standard deviation was calculated, and statistical significance was determined by Student\'s *t* test.

Similarly, for the measurement of the relative fluorescence intensity of spindle pole LGN, a 60-pixel circle was drawn around each spindle pole and in areas 10 pixels away using ImageJ software. Fluorescence intensities at the spindle poles and the cytosol were referred to as *F*(spindle pole) and *F*(cytosol), respectively. The ratio *F*(spindle pole)/*F*(cytosol) was collected for each group of cells and analyzed.

FRAP analysis
-------------

Stable Tet-Off MDCK cells expressing Venus-LGN were cultured in the absence (--Dox) of doxycycline to allow expression of low levels of Venus-LGN. Untreated cells or cells transfected with either control shRNA or DYNC1H1 shRNA were grown on Delta T dishes (Bioptechs, Butler, PA) in DMEM supplemented with 10% fetal calf serum (FCS) and antibiotics. At 1 h before FRAP analysis, the medium was replaced with F10 medium containing 10% FCS, and dimethyl sulfoxide (DMSO; 0.5%) or 50 nM nocodazole was added in the medium as needed. The dish was then placed in a temperature control system (Bioptechs) that maintained a temperature of 37°C during the FRAP experiment. FRAP experiments were performed on a LSM 7 live laser-scanning confocal microscope (Carl Zeiss) with a plan-Apochromat 63×/NA 1.4 oil objective. Because LGN accumulates at the cell cortex only during mitosis, it is easy to identify mitotic cells showing cortical Venus-LGN signal. We specifically chose those cortical areas where Venus-LGN fluorescence was relatively bright and smooth as the regions of interest (ROIs), which were 4 μm^2^ in size and centered on the cortical Venus-LGN fluorescence. ROIs were first scanned with a 488-nm diode laser at 1.1% power for three cycles (10 s each cycle) to determine a measurement of initial fluorescence intensity in the ROI. Next ROIs were subjected to 12 iterations with 488-nm diode laser at 100% power to photobleach the ROI. The fluorescent images were then acquired every 10 s at 1.1% laser power for another 37 cycles using ZEN 2009 software (Carl Zeiss). The fluorescence recovery in the ROI at every time point was normalized according to 100(*I~t~* − *I*~0~)/(*I~c~* − *I*~0~), where *I~t~* represents fluorescence intensity in the ROI at the given time point, *I*~0~ represents the intensity of fluorescence in ROI after photobleaching, and *I~c~* represents the average value of three measurements of the fluorescence intensity in the ROI before photobleaching. Recovery measurements were quantified by fitting normalized fluorescence intensities of bleached areas to a one-phase exponential association by using ZEN 2009 software (Carl Zeiss). Standard SEM was calculated, and statistical significance was determined by Student\'s *t* test.
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DYNC1H1

:   dynein heavy chain, cytoplasmic 1

DYNC1I1

:   dynein IC 1

FRAP

:   fluorescence recovery after photobleaching

LatA

:   latrunculin A

LGN

:   mammalian homologue of *Drosophila* Partner of Inscuteable

MT

:   microtubule

NuMA

:   nuclear mitotic apparatus
